about
Statins in heart failure: do we need another trial?Lipid abnormalities in kidney disease and management strategiesApolipoprotein E polymorphism and atherosclerosis.Influence of smoking on predictors of vascular disease.The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.Dyslipoproteinemia and peripheral arterial occlusive disease.Matrix metalloproteinases and diabetic vascular complications.Circulatory syndrome: an evolution of the metabolic syndrome concept!Secondary prevention of ischemic cerebrovascular disease. What is the evidence?Statins: another class of antihypertensive agents?Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview.The role of established and emerging risk factors in peripheral vascular graft occlusion.Clinical profile of long-term survivors and nonsurvivors with type 2 diabetes.Multiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pleiotropic effects in reno-, cardio- and neuroprotection.Management of transplant renal artery stenosis.Risks and benefits of statin use in young people with type 1 diabetes.The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study.Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemia.Cyclosporine A and lovastatin: the good and the bad, but who will be the winner?Are statins an option in the management of abdominal aortic aneurysms?Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy.Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus.The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease.Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease.Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort.Risk modification in patients with peripheral arterial disease: a retrospective survey.Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease.
P2860
Q26998966-443E91B9-251B-4C4E-B0FF-7D7B27859552Q27024982-9BF32620-4396-483D-85CA-082CBA2BAB9FQ35068761-41F5FB3D-AA3B-46E5-A92D-536787545B1AQ35562469-8000EDE6-A7B3-40B1-B129-E67B4F801E80Q35587723-4F0D3B28-9BFC-400F-A664-329CC33B4AF2Q35693903-7963A8CF-24D5-4398-BE52-A775BCB67410Q36081593-41D2502E-5F3F-4D8F-AFA7-FD3E7ADA51C5Q36087928-30BD01B3-3474-41C0-BE99-63518B2FA06BQ36271814-3AEC294D-AE64-4F3F-B7DA-E3766E298A19Q36411099-45CA81CA-2FD4-4CD2-8756-AD527D3B430DQ36653658-14A85D3E-540D-4CE7-9C06-6D333AC17B5CQ36808026-A5BD4390-4592-4743-A0F2-FD8679F30876Q37022541-8665BBF9-5834-4186-82E9-0D567DA52C66Q37247753-89C132DA-64E6-4BC8-8D84-BB54DE17B77EQ37777528-F851AC74-A470-4BDF-9DB3-4ABE312D48B6Q38209424-ADD6DA01-B98F-417C-AA29-06E63C991CBEQ40088029-CAFE436D-90F1-45E5-958F-4C662E2B0A0AQ43416438-0FC8FB94-FD24-43F9-B31C-0A66A139F06BQ44294762-B4C10DC6-83CB-4219-8867-BC0338C494C9Q44496850-097C436D-9CFE-425D-AD43-0E048CAC9126Q44622602-EA822106-4B10-4A5D-86DC-D5BD8302BFE8Q44687349-1279EFFA-5540-4149-A86E-061AD986301FQ44753301-20D312F1-D727-4730-9752-28FF0BA1421CQ44960569-C2AD080C-CFB5-4EFD-971A-6677AC011FCBQ45065894-FA8EDC6B-E853-4935-B31D-8EBC79A5DC63Q46486524-48B60903-A4B5-4265-8651-61E2294AD288Q46727401-69A65110-79C7-48DB-971D-829B1EEEB878Q46917502-CF9ACD8A-8C11-4EFD-9169-8BF45AC5D9DD
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Statins and renal function.
@ast
Statins and renal function.
@en
Statins and renal function.
@nl
type
label
Statins and renal function.
@ast
Statins and renal function.
@en
Statins and renal function.
@nl
prefLabel
Statins and renal function.
@ast
Statins and renal function.
@en
Statins and renal function.
@nl
P2860
P1433
P1476
Statins and renal function.
@en
P2093
Moses Elisaf
P2860
P304
P356
10.1177/000331970205300501
P577
2002-09-01T00:00:00Z